PBYI
Puma Biotechnology, Inc.
$8.53
+0.13 (+1.55%)
At close · Jul 17
Market Cap
$434.17M
Shares
50,899,456
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-16 | 2026-06-11 | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-28 | 2026-06-11 | |
| 8-K | 2026-02-26 | — | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-08-07 | — | |
| 10-Q/A | 2025-08-07 | 2025-03-31 | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-06-24 | 2025-06-19 | |
| 8-K | 2025-06-13 | 2025-06-11 | |
| 8-K | 2025-05-09 | 2025-05-08 | |
| 8-K | 2025-05-08 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| DEF 14A | 2025-04-28 | 2025-06-11 | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-02-27 | — | |
| 8-K | 2024-11-07 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-09-16 | 2024-09-12 | |
| 8-K | 2024-08-15 | 2024-08-14 | |
| 8-K | 2024-08-07 | 2024-08-06 | |
| 8-K | 2024-08-01 | — | |
| 10-Q | 2024-08-01 | 2024-06-30 | |
| 8-K | 2024-06-24 | 2024-06-18 | |
| 8-K | 2024-05-17 | — | |
| 10-Q | 2024-05-02 | 2024-03-31 | |
| 8-K | 2024-05-02 | — | |
| DEF 14A | 2024-04-26 | 2024-06-18 | |
| 8-K | 2024-03-19 | 2024-03-18 | |
| 10-K | 2024-02-29 | 2023-12-31 | |
| 8-K | 2024-02-29 | — | |
| 8-K | 2024-01-18 | — | |
| 10-Q | 2023-11-02 | 2023-09-30 | |
| 8-K | 2023-11-02 | — | |
| 8-K | 2023-09-26 | — | |
| 8-K | 2023-08-18 | 2023-08-17 | |
| 8-K | 2023-08-03 | — | |
| 10-Q | 2023-08-03 | 2023-06-30 | |
| 8-K | 2023-06-15 | 2023-06-13 | |
| 8-K | 2023-05-04 | — | |
| 10-Q | 2023-05-04 | 2023-03-31 | |
| DEF 14A | 2023-04-28 | 0001-01-01 | |
| 8-K | 2023-03-02 | — | |
| 10-K | 2023-03-02 | 2022-12-31 | |
| 8-K | 2023-01-09 | — | |
| 8-K | 2022-12-16 | 2022-12-13 |
Showing 1–50 of 102 filings
Key facts
CIK
1401667
CUSIP
74587V107
13F (30d)
17 filings
12 filers
Visit website
Investor relations